Evidence map›Paper›PMID 30227674›Full record

ArticleJournal of clinical medicine2018

Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study.

GianLuca Colussi, Francesca Zuttion, Bruno Bais, Pierluigi Dolso, Mariarosaria Valente, Gian Luigi Gigli, Daniele Gasparini, Massimo Sponza, Cristiana Catena, Leonardo A Sechi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

GianLuca ColussiDivision of Internal Medicine, Department of Medicine, University of Udine, 33100 Udine, Italy. gianluca.colussi@uniud.it.
Francesca ZuttionDivision of Internal Medicine, Department of Medicine, University of Udine, 33100 Udine, Italy. fiammetta.zutt@gmail.com.
Bruno BaisDivision of Internal Medicine, Department of Medicine, University of Udine, 33100 Udine, Italy. bruno.bais@asuiud.sanita.fvg.it.
Pierluigi DolsoDivision of Neurology, Department of Medicine, University of Udine, 33100 Udine, Italy. pierluigi.dolso@asuiud.sanita.fvg.it.
Mariarosaria ValenteDivision of Neurology, Department of Medicine, University of Udine, 33100 Udine, Italy. mariarosaria.valente@uniud.it.
Gian Luigi GigliDivision of Neurology, Department of Medicine, University of Udine, 33100 Udine, Italy. gianluigi.gigli@uniud.it.
Daniele GaspariniDivision of Interventional Radiology, Department of Radiology, Academic Hospital of Udine, 33100 Udine, Italy. ozoudine@gmail.com.
Massimo SponzaDivision of Interventional Radiology, Department of Radiology, Academic Hospital of Udine, 33100 Udine, Italy. massimo.sponza@asuiud.sanita.fvg.it.
Cristiana CatenaDivision of Internal Medicine, Department of Medicine, University of Udine, 33100 Udine, Italy. cristiana.catena@uniud.it.
Leonardo A SechiDivision of Internal Medicine, Department of Medicine, University of Udine, 33100 Udine, Italy. leonardo.sechi@uniud.it.
Alessandro CavarapeDivision of Internal Medicine, Department of Medicine, University of Udine, 33100 Udine, Italy. alessandro.cavarape@uniud.it.
University of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carotid artery stenting (CAS) is a minimal invasive procedure used to resolve carotid occlusion that can be affected by peri-procedural complications. Statin use before CAS has shown to reduce peri-procedural risk and improve survival, though time-dependent cofactors that influence mortality has not been considered. The aim of this study was to evaluate long-term survival of patients who undergo CAS considering new occurred major adverse cardiovascular event (MACE) as time-dependent cofactor. In this study, 171 high cardiovascular risk patients (age 72 ± 8 years, 125 males) were enrolled after CAS procedure and were followed for a median of 8.4 years. Death occurred in 44% of patients with a mean time to death of 69 ± 39 months and MACE in 34% with a mean time of 35 ± 42 months. In patients who used or not statins at baseline, death occurred in 33% and 65%, respectively (

Indexed as

atherosclerosiscardiovascular eventcarotid artery stentingmortalitystatins

Identifiers

PMID30227674
PMCPMC6162515
OpenAlexW2889902360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.